XML 127 R24.htm IDEA: XBRL DOCUMENT
v3.26.1

Licensing, Acquisitions and Other Arrangements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Licensing, Acquisitions, and Other Arrangements |
Schedule of Research and Development Assets Acquired Other than Through Business Combination | The following table summarizes acquired IPR&D and milestones expense:
| Three months ended March 31,
(in millions) | 2026 |  | 2025
Upfront charges | $ | 703 |  |  | $ | 246 |
Development milestones | 41 |  |  | 2 |
Acquired IPR&D and milestones | $ | 744 |  |  | $ | 248 |

X
- References No definition available. + Details
Name: | abbv_AcquisitionsCollaborationsAndOtherArrangementsDisclosureAbstract
Namespace Prefix: | abbv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of capitalized cost and amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1 + Details
Name: | us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration